SAN DIEGO--(BUSINESS WIRE)--Halozyme Therapeutics, Inc. (Nasdaq:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets, today announced that management will present at the Jefferies 3rd Annual Healthcare Conference on Wednesday, June 17, 2009 at 9:00 a.m. ET (6:00 a.m. PT) in New York City.
